Please login to the form below

Not currently logged in
Email:
Password:

Lexington Communications promotes Joanne Bullen

She takes on leadership of its UK and international healthcare practice

Lexington Communications Joanne BullenLondon-based agency Lexington Communications has appointed Joanne Bullen to lead its UK and international health practice.

She currently serves as director of international operations at Lexington Health and will take on the UK healthcare practice position when the current director, Jessica Fine, moves to MSD in April.

Mike Craven, a partner at Lexington Communications, said: “Jo Bullen and Jess Fine have worked together over the last few years to create a market-leading health offer.

“Jo, who is one of our most experienced directors, will now lead both the UK and international health business.”

Bullen brings over 20 years of strategic counsel expertise to the role, and prior to joining Lexington Health served as a senior director at US-based PR firm APCO Worldwide.

She said: “I believe the team is one of the best in the market, partnering with some of the most exciting healthcare companies around the world.

“I look forward to working with the excellent Lexington team in our London and Manchester offices to build on our success delivering first class, innovative and results-driven work for our clients.”

29th February 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

OPEN Health Graduates and the XP Support Group
During our graduate induction period in September 2018, we were asked to find a charity that could benefit from the expertise of the OPEN Health practices. We made the decision...
Alexander Devine Website has gone live!
As part of the OPEN Health CSR programme one of the charities we support is Alexander Devine. They are a local Children's Hospice based in Maidenhead who provide a truly...
Drug pricing and competition
Strengthening business competition and reducing anti-competitive practices
How the CMA is tackling high prices for essential drugs...

Infographics